Follow-up Study for Participants of Jointstem Investigator Initiated Trial by Arthroscopy
Launched by R-BIO · Mar 29, 2021
Trial Information
Current as of July 22, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking to follow up with patients who previously participated in a study using a treatment called "jointstem" for knee arthritis. The main goal is to check how safe this treatment is over a longer period for people who have degenerative arthritis in their knees. If you took part in the earlier study and signed the consent form, you might be eligible to join this follow-up study.
Currently, the trial is not yet recruiting participants, but it is open to individuals of all ages who were part of the Jointstem study. If you join, you can expect to share your experiences and any health updates regarding your knee condition. Your feedback will help researchers understand the long-term effects of the jointstem treatment. There are no specific exclusion criteria, so most previous participants may qualify. This study aims to ensure that the treatment remains safe and effective for those who need it.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Participants of Jointstem IIT by arthroscopy (BS-JS-IIT1)
- • Participants who signed informed consent document of this study
- Exclusion Criteria:
- • No applicable
About R Bio
r-bio is a leading clinical trial sponsor dedicated to advancing biomedical research and innovation. With a focus on developing cutting-edge therapies and diagnostics, r-bio leverages a robust portfolio of expertise in clinical trial management, regulatory affairs, and data analysis. Committed to improving patient outcomes, r-bio collaborates with healthcare professionals, research institutions, and industry partners to streamline the clinical development process. Through rigorous scientific methodologies and a patient-centered approach, r-bio aims to bring transformative solutions to market, contributing to the overall advancement of healthcare.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials